Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II/III Clinical Trial of NPC-15 - Verification of the Efficacy for Sleep Disorders of Children With Autism Spectrum Disorders -

NCT02757066 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.

NCT NCT02757066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02757066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II/III Clinical Trial of NPC-15 - Verification of the Efficacy for Sleep Disorders of Children With Autism Spectrum Disorders -
Lead sponsor
Nobelpharma
Phase
Phase 2/3
Overall status
Completed
Start date
June 16, 2016
Completion date
September 14, 2018
Enrollment
196 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, sleep disorders